Vaxinano
Vaxinano is engaged in the development of prophylactic and therapeutic vaccines for infectious diseases, for human and animal health markets. The company is using nanoparticles made of starch and lipids (nanovectors) to develop vaccines. The company's experimental vaccines target toxoplasmosis and tuberculosis and developing anti-bacterial, antiviral and antiparasitic vaccines. The company operates in the Infectious…
Funding snapshot
About
Vaxinano is engaged in the development of prophylactic and therapeutic vaccines for infectious diseases, for human and animal health markets. The company is using nanoparticles made of starch and lipids (nanovectors) to develop vaccines. The company's experimental vaccines target toxoplasmosis and tuberculosis and developing anti-bacterial, antiviral and antiparasitic vaccines. The company operates in the Infectious Diseases sector with additional focus on Infectious Diseases and Immunotherapy. Its business model centers on Vaccine. Founded in 2016, headquartered in Lille, France. The company has raised $6.5M at the Series A stage. Backed by investors including TCD Capital, Nord France Amorquage, WiSEED, Bpifrance, Captechsantenutrition and others.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drug Delivery > Vaccine,
Infectious Diseases > Drugs > Diversified,
Drug Delivery > Nanoparticle Based
Team background
College Wise > HEC Paris
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.